Investor Relations
Our Releases and Financials are available at OTCMarkets.com- Achieves sales growth of 9% and reports net income of $641,326
- Generated positive cashflow for fourth consecutive year
- Generates positive cash flow for 3rd consecutive year
- Generates positive cash flow for 3rd consecutive year
- Online mail-order pharmacy recieves VIPPS re-accreditation; Launches "First Order Free" campaign
- Online mail-order pharmacy selected for “Healthcare in America” documentary
- Online pharmacy net sales grew $1.2 million or 45%, 3Q 2017 versus 3Q 2016
- Online pharmacy net sales grow $1.5 million or 62% 2Q 2017 versus 2Q 2016
- Election of Chief Executive Officer and President Fills Board Vacancy
- Online and mail-order pharmacy year-over-year net sales grow 48% and exceed $10M
- Online and mail-order pharmacy year-over-year net sales grow 60.8 percent
- New Customers Grow 140% and Core Prescription Sales Grow Record 49.3%
- Core Prescription Sales Grow 63.3% and New Customers Grow 198.5%
- Continued Sales & Gross Margin Expansion with Significant Reduction of Net Loss
- New Customers Grow 70.3% as Prescription Drug Orders Grow 17.3%
- Gross Margin Increases to 67% While Net Loss Narrows by 78.2%
- Net Loss Narrows by 65.6% While Gross Margin Remains Steady at 61%